A Phase 1, Open-label, Randomized, Crossover Clinical Trial in Healthy Normal Volunteers to Evaluate the Bioequivalence of 30 U TI Inhalation Powder Delivered by Gen2 Inhaler Using One 30 U Cartridge Versus a Combination of 10 U and 20 U Cartridges
Phase of Trial: Phase I
Latest Information Update: 15 Dec 2014
Price : $35 *
At a glance
- Drugs Insulin (Primary) ; Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors MannKind Corporation
- 11 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 May 2014 to 1 Aug 2014.
- 10 Apr 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Mar 2014 to 1 May 2014.